Boehringer Ingelheim entered into a series of agreements. Boehringer and FivePrime formed a research and license agreement to discover novel therapeutics to treat rheumatoid arthritis. Boehringer acquired rights for Ingenuity Systems’ Ingenuity Pathways Analysis software. Vectura Group and Boehringer collaborated to develop dry powder inhalers to treat respiratory diseases.